Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis

• Main Authors: Kay Khine Soe (Author), Thanachit Krikeerati (Author), Chatkamol Pheerapanyawaranun (Author), Suvimol Niyomnaitham (Author), Phichayut Phinyo (Author), Torpong Thongngarm (Author)
• Format: Bog
• Udgivet: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). This network meta-analysis assessed the comparative efficacy and acceptability of licensed dose aqueous INCSs. PubMed/MEDLINE, Scopus, EMBASE, and the Cochrane C...